Aflac (NYSE:AFL) PT Raised to $100.00

Aflac (NYSE:AFL) had its target price lifted by analysts at Piper Sandler from $95.00 to $100.00 in a research note issued on Friday, Benzinga reports. The firm currently has an “overweight” rating on the financial services provider’s stock. Piper Sandler’s price target suggests a potential upside of 11.97% from the company’s current price.

Several other equities research analysts also recently weighed in on AFL. Truist Financial raised their price objective on Aflac from $80.00 to $82.00 and gave the company a “hold” rating in a report on Friday, May 3rd. Wells Fargo & Company raised their price objective on Aflac from $81.00 to $82.00 and gave the company an “equal weight” rating in a report on Friday, May 10th. Morgan Stanley raised their price objective on Aflac from $80.00 to $84.00 and gave the company an “equal weight” rating in a report on Monday, April 15th. StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a report on Friday, May 3rd. Finally, Keefe, Bruyette & Woods lifted their target price on Aflac from $83.00 to $87.00 and gave the stock a “market perform” rating in a report on Wednesday, April 10th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $83.46.

Aflac Price Performance

Aflac stock opened at $89.31 on Friday. The stock’s fifty day moving average price is $87.03 and its two-hundred day moving average price is $83.82. Aflac has a one year low of $68.34 and a one year high of $91.15. The company has a debt-to-equity ratio of 0.34, a current ratio of 0.08 and a quick ratio of 0.08. The firm has a market cap of $50.75 billion, a PE ratio of 9.86, a price-to-earnings-growth ratio of 2.20 and a beta of 0.96.

Aflac (NYSE:AFL) last issued its quarterly earnings results on Monday, May 6th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.58 by $0.08. Aflac had a return on equity of 16.88% and a net margin of 27.67%. The company had revenue of $5.44 billion for the quarter, compared to analyst estimates of $4.09 billion. During the same quarter last year, the company posted $1.55 EPS. The company’s revenue for the quarter was up 13.3% compared to the same quarter last year. As a group, research analysts expect that Aflac will post 6.46 EPS for the current fiscal year.

Insiders Place Their Bets

In other Aflac news, Director Joseph L. Moskowitz sold 600 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. The stock was sold at an average price of $84.84, for a total transaction of $50,904.00. Following the completion of the sale, the director now directly owns 27,550 shares of the company’s stock, valued at approximately $2,337,342. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Joseph L. Moskowitz sold 600 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. The stock was sold at an average price of $84.84, for a total value of $50,904.00. Following the transaction, the director now owns 27,550 shares in the company, valued at approximately $2,337,342. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Charles D. Lake II sold 22,378 shares of the business’s stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $87.47, for a total value of $1,957,403.66. Following the completion of the transaction, the director now owns 61,522 shares in the company, valued at approximately $5,381,329.34. The disclosure for this sale can be found here. Corporate insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Aflac

Several institutional investors and hedge funds have recently bought and sold shares of AFL. Jaffetilchin Investment Partners LLC boosted its holdings in shares of Aflac by 1.7% in the first quarter. Jaffetilchin Investment Partners LLC now owns 7,254 shares of the financial services provider’s stock worth $623,000 after acquiring an additional 121 shares during the period. Flputnam Investment Management Co. boosted its stake in Aflac by 0.5% during the fourth quarter. Flputnam Investment Management Co. now owns 25,031 shares of the financial services provider’s stock valued at $2,065,000 after buying an additional 122 shares during the period. ICA Group Wealth Management LLC boosted its stake in Aflac by 4.3% during the fourth quarter. ICA Group Wealth Management LLC now owns 2,974 shares of the financial services provider’s stock valued at $245,000 after buying an additional 122 shares during the period. TKG Advisors LLC boosted its stake in Aflac by 0.5% during the first quarter. TKG Advisors LLC now owns 24,536 shares of the financial services provider’s stock valued at $2,107,000 after buying an additional 122 shares during the period. Finally, PDS Planning Inc boosted its stake in Aflac by 4.7% during the first quarter. PDS Planning Inc now owns 2,761 shares of the financial services provider’s stock valued at $237,000 after buying an additional 125 shares during the period. 67.44% of the stock is owned by institutional investors.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.